Works by Badrising, Umesh A.


Results: 12
    1

    Autoantibodies to cytosolic 5'-nucleotidase 1A in inclusion body myositis.

    Published in:
    2013
    By:
    • Pluk, Helma;
    • van Hoeve, Bas J A;
    • van Dooren, Sander H J;
    • Stammen-Vogelzangs, Judith;
    • van der Heijden, Annemarie;
    • Schelhaas, Helenius J;
    • Verbeek, Marcel M;
    • Badrising, Umesh A;
    • Arnardottir, Snjolaug;
    • Gheorghe, Karina;
    • Lundberg, Ingrid E;
    • Boelens, Wilbert C;
    • van Engelen, Baziel G;
    • Pruijn, Ger J M
    Publication type:
    Journal Article
    2

    Autoantibodies to cytosolic 5′-nucleotidase 1A in inclusion body myositis.

    Published in:
    Annals of Neurology, 2013, v. 73, n. 3, p. 397, doi. 10.1002/ana.23822
    By:
    • Pluk, Helma;
    • Hoeve, Bas J. A.;
    • Dooren, Sander H. J.;
    • Stammen‐Vogelzangs, Judith;
    • Heijden, Annemarie;
    • Schelhaas, Helenius J.;
    • Verbeek, Marcel M.;
    • Badrising, Umesh A.;
    • Arnardottir, Snjolaug;
    • Gheorghe, Karina;
    • Lundberg, Ingrid E.;
    • Boelens, Wilbert C.;
    • Engelen, Baziel G.;
    • Pruijn, Ger J. M.
    Publication type:
    Article
    3

    Comparison of weakness progression in inclusion body myositis during treatment with methotrexate or placebo.

    Published in:
    2002
    By:
    • Badrising, Umesh A.;
    • Maat-Schieman, Marion L.C.;
    • Ferrari, Michel D.;
    • Zwinderman, Aeilko H.;
    • Wessels, Judith A.M.;
    • Breedveld, Ferdinand C.;
    • van Doorn, Pieter A.;
    • van Engelen, Baziel G.M.;
    • Hoogendijk, Jessica E.;
    • Höweler, Chris J.;
    • de Jager, Aeiko E.;
    • Jennekens, Frans G.I.;
    • Koehler, Peter J.;
    • de Visser, Marianne;
    • Viddeleer, Alain;
    • Verschuuren, Jan J.;
    • Wintzen, Axel R.;
    • Höweler, Chris J
    Publication type:
    journal article
    4

    Inclusion body myositis.

    Published in:
    Journal of Neurology, 2005, v. 252, n. 12, p. 1448, doi. 10.1007/s00415-005-0884-y
    By:
    • Badrising, Umesh A.;
    • Maat-Schieman, Marion L. C.;
    • van Houwelingen, Johannes C.;
    • van Doorn, Pieter A.;
    • van Duinen, Sjoerd G.;
    • van Engelen, Baziel G. M.;
    • Faber, Carin G.;
    • Hoogendijk, Jessica E.;
    • de Jager, Aeiko E.;
    • Koehler, Peter J.;
    • de Visser, Marianne;
    • Verschuuren, Jan J. G. M.;
    • Wintzen, Axel R.
    Publication type:
    Article
    5
    6
    7

    Phase 1 clinical trial of losmapimod in facioscapulohumeral dystrophy: Safety, tolerability, pharmacokinetics, and target engagement.

    Published in:
    British Journal of Clinical Pharmacology, 2021, v. 87, n. 12, p. 4658, doi. 10.1111/bcp.14884
    By:
    • Mellion, Michelle L.;
    • Ronco, Lucienne;
    • Berends, Cecile L.;
    • Pagan, Lisa;
    • Brooks, Sander;
    • van Esdonk, Michiel J.;
    • van Brummelen, Emilie M. J.;
    • Odueyungbo, Adefowope;
    • Thompson, Lorin A.;
    • Hage, Michelle;
    • Badrising, Umesh A.;
    • Raines, Shane;
    • Tracewell, William G.;
    • van Engelen, Baziel;
    • Cadavid, Diego;
    • Groeneveld, Geert J.
    Publication type:
    Article
    8
    9
    10
    11
    12